Literature DB >> 24857852

Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism - an abscopal neuroprotective effect.

D M Johnstone1, N el Massri2, C Moro3, S Spana4, X S Wang5, N Torres3, C Chabrol3, X De Jaeger3, F Reinhart3, S Purushothuman4, A-L Benabid3, J Stone4, J Mitrofanis6.   

Abstract

We have previously shown near infrared light (NIr), directed transcranially, mitigates the loss of dopaminergic cells in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-treated mice, a model of parkinsonism. These findings complement others suggesting NIr treatment protects against damage from various insults. However one puzzling feature of NIr treatment is that unilateral exposure can lead to a bilateral healing response, suggesting NIr may have 'indirect' protective effects. We investigated whether remote NIr treatment is neuroprotective by administering different MPTP doses (50-, 75-, 100-mg/kg) to mice and treating with 670-nm light directed specifically at either the head or body. Our results show that, despite no direct irradiation of the damaged tissue, remote NIr treatment produces a significant rescue of tyrosine hydroxylase-positive cells in the substantia nigra pars compacta at the milder MPTP dose of 50-mg/kg (∼30% increase vs sham-treated MPTP mice, p<0.05). However this protection did not appear as robust as that achieved by direct irradiation of the head (∼50% increase vs sham-treated MPTP mice, p<0.001). There was no quantifiable protective effect of NIr at higher MPTP doses, irrespective of the delivery mode. Astrocyte and microglia cell numbers in substantia nigra pars compacta were not influenced by either mode of NIr treatment. In summary, the findings suggest that treatment of a remote tissue with NIr is sufficient to induce protection of the brain, reminiscent of the 'abscopal effect' sometimes observed in radiation treatment of metastatic cancer. This discovery has implications for the clinical translation of light-based therapies, providing an improved mode of delivery over transcranial irradiation.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MPTP; Parkinson’s disease; mouse model; near infrared light; neuroprotection

Mesh:

Substances:

Year:  2014        PMID: 24857852     DOI: 10.1016/j.neuroscience.2014.05.023

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.708


  34 in total

1.  Photobiomodulation and the brain: a new paradigm.

Authors:  Madison Hennessy; Michael R Hamblin
Journal:  J Opt       Date:  2016-12-14       Impact factor: 2.516

Review 2.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 3.  Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.

Authors:  Sayon Roy; Timothy S Kern; Brian Song; Caren Stuebe
Journal:  Am J Pathol       Date:  2016-11-12       Impact factor: 4.307

4.  Photobiomodulation-induced changes in a monkey model of Parkinson's disease: changes in tyrosine hydroxylase cells and GDNF expression in the striatum.

Authors:  Nabil El Massri; Ana P Lemgruber; Isobel J Rowe; Cécile Moro; Napoleon Torres; Florian Reinhart; Claude Chabrol; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2017-03-15       Impact factor: 1.972

Review 5.  Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends.

Authors:  Namgue Hong
Journal:  Biomed Eng Lett       Date:  2019-06-12

Review 6.  Light-emitting diode phototherapy: pain relief and underlying mechanisms.

Authors:  Wen-Wen Zhang; Xin-Yue Wang; Yu-Xia Chu; Yan-Qing Wang
Journal:  Lasers Med Sci       Date:  2022-04-11       Impact factor: 3.161

Review 7.  Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation.

Authors:  Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2018-01-19       Impact factor: 3.421

Review 8.  Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

Authors:  Song Li; Jie Dong; Cheng Cheng; Weidong Le
Journal:  J Neural Transm (Vienna)       Date:  2016-08-11       Impact factor: 3.575

Review 9.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

10.  Near-infrared light treatment reduces astrogliosis in MPTP-treated monkeys.

Authors:  Nabil El Massri; Cécile Moro; Napoleon Torres; Fannie Darlot; Diane Agay; Claude Chabrol; Daniel M Johnstone; Jonathan Stone; Alim-Louis Benabid; John Mitrofanis
Journal:  Exp Brain Res       Date:  2016-07-05       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.